BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Suven Life Sciences Ltd Revenue Growth At 13.42%; PAT Up By 29.15% For The Half Year Ended Sept, 2016

  November 28, 2016

   · 

  1 min read
• Drug Development

  MabVax Therapeutics Enrolls First Patients In Expansion Of Phase I Clinical Trial Treating Newly Diagnosed Pancreatic Cancer Patients

  November 28, 2016

   · 

  4 min read
• Stem Cell Network Release: Funding To Support Innovative Stem Cell Research On Septic Shock, Diabetes, Brain Injury & 3D Printing Of Neural Tissues

  November 28, 2016

   · 

  4 min read
• Drug Development

  PhaseRx Receives Orphan Drug Designation From FDA For PRX-OTC For The Treatment Of Ornithine Transcarbamylase Deficiency

  November 28, 2016

   · 

  6 min read
• Drug Development

  Cognition Therapeutics Sees Eli Lilly Solanezumab Clinical Trial Results As Support For Its Unique Mechanism For Treatment Of Alzheimer’s Disease

  November 28, 2016

   · 

  4 min read
• Drug Development

  Araim Pharmaeuticals Release: ARA 290 Obtains European Union Orphan Drug Designation For Prevention Of Graft Loss In Pancreatic Islet Transplantation

  November 28, 2016

   · 

  5 min read
• Business

  Cascadian Therapeutics Strengthens Management Team With Key Hires, Monique M. Greer And Marc C. Chamberlain, M.D.

  November 28, 2016

   · 

  3 min read
• Drug Development

  Global Blood Therapeutics Announces Initiation Of Phase IIa Trial Of GBT440 In Idiopathic Pulmonary Fibrosis (IPF)

  November 28, 2016

   · 

  5 min read
• Business

  Cellectar Biosciences Announces Partnership With Radiopharmaceutical Specialists, CPDC, To Establish Manufacturing Capacity In Anticipation Of CLR 131 Pivotal Trial And Commercial Production

  November 28, 2016

   · 

  6 min read
• Business

  Advanced Accelerator Applications Reports 15.4% Sales Growth In The Third Quarter Of 2016 And Feedback From The FDA For Lutathera, An Investigational Treatment For Neuroendocrine Tumors

  November 28, 2016

   · 

  1 min read